Literature DB >> 12376508

Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations.

Sabina Rinaldi1, Annabelle Geay, Henri Déchaud, Carine Biessy, Anne Zeleniuch-Jacquotte, Arslan Akhmedkhanov, Roy E Shore, Elio Riboli, Paolo Toniolo, Rudolf Kaaks.   

Abstract

In this study, we validated measurements of free testosterone (fT) and free estradiol (fE(2)) concentrations calculated from total serum concentrations of testosterone (T), estradiol (E(2)), and sex hormone-binding globulin (SHBG), measured by direct, commercial radioimmunoassays, by comparison with reference measurements obtained by dialysis plus an in-house radioimmunoassay after extraction and chromatographic purification. The study was conducted in serum samples from 19 postmenopausal women who were part of an ongoing prospective cohort study. We also performed sensitivity analyses to examine the robustness of the theoretical calculations. Sensitivity analyses showed that in this population, competitive binding of dihydrotestosterone and total T could be ignored in the calculation of fE(2), and competitive binding by dihydrotestosterone does not need to be taken into account for calculation of fT. Furthermore, variations in albumin and SHBG concentrations had negligible effects on fT and fE(2) calculations. Values of fT and fE(2), calculated from total T and E(2) concentrations obtained by the same in-house radioimmunoassay used for the dialysis method, correlated highly with the measurements by dialysis (Pearson's coefficients of correlation above 0.97). When calculating fT and fE(2) using total T and total E(2) concentrations obtained by different direct radioimmunoassays, almost all kits gave good correlations with the reference method for fT (Pearson's r > 0.83), but only a few gave good correlations for fE(2) (Diagnostic System Laboratories and DiaSorin; r > 0.80). The direct radioimmunoassays giving the best correlation for fT and fE(2) with the dialysis method were those that best measured total concentrations of T and E(2). Furthermore, mean values of fT and fE(2) corresponded well to mean values by the reference method if SHBG measurements were also well calibrated. We conclude that in postmenopausal women, theoretical calculations are valid for the determination of fT and fE(2) concentrations and can give reliable estimation of cancer risk in epidemiological studies when the total concentrations of T, E(2), and SHBG are measured accurately.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376508

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  104 in total

1.  Effect of statins on estrogen and androgen levels in postmenopausal women treated with estradiol.

Authors:  A Peck; S Chaikittisilpa; R Mirzaei; J Wang; W J Mack; H N Hodis; F Z Stanczyk
Journal:  Climacteric       Date:  2010-05-07       Impact factor: 3.005

2.  The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.

Authors:  B Delia Johnson; Kathleen M Dwyer; Frank Z Stanczyk; Vera Bittner; Sarah L Berga; Glenn D Braunstein; Ricardo Azziz; YuChing Yang; Georgina E Hale; C Noel Bairey Merz
Journal:  J Clin Endocrinol Metab       Date:  2010-06-16       Impact factor: 5.958

3.  Adolescent diet and subsequent serum hormones, breast density, and bone mineral density in young women: results of the Dietary Intervention Study in Children follow-up study.

Authors:  Joanne F Dorgan; Lea Liu; Catherine Klifa; Nola Hylton; John A Shepherd; Frank Z Stanczyk; Linda G Snetselaar; Linda Van Horn; Victor J Stevens; Alan Robson; Peter O Kwiterovich; Norman L Lasser; John H Himes; Kelley Pettee Gabriel; Andrea Kriska; Elizabeth H Ruder; Carolyn Y Fang; Bruce A Barton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

4.  Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.

Authors:  Nada Assi; Sabina Rinaldi; Vivian Viallon; S Ghazaleh Dashti; Laure Dossus; Agnès Fournier; Iris Cervenka; Marina Kvaskoff; Renée Turzanski-Fortner; Manuela Bergmann; Heiner Boeing; Salvatore Panico; Fulvio Ricceri; Domenico Palli; Rosario Tumino; Sara Grioni; María José Sánchez Pérez; María-Dolores Chirlaque; Catalina Bonet; Aurelio Barricarte Gurrea; Pilar Amiano Etxezarreta; Susana Merino; H Bas Bueno de Mesquita; Carla H van Gils; Charlotte Onland-Moret; Anne Tjønneland; Kim Overvad; Antonia Trichopoulou; Georgia Martimianaki; Anna Karakatsani; Tim Key; Sofia Christakoudi; Merete Ellingjord-Dale; Kostas Tsilidis; Elio Riboli; Rudolf Kaaks; Marc J Gunter; Pietro Ferrari
Journal:  Int J Cancer       Date:  2019-04-30       Impact factor: 7.396

5.  Age at menarche, androgen concentrations, and midlife obesity: findings from the Midlife Women's Health Study.

Authors:  Lisa Gallicchio; Jodi A Flaws; Rebecca L Smith
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

6.  Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk.

Authors:  Alison M Mondul; Sabine Rohrmann; Andy Menke; Manning Feinleib; William G Nelson; Elizabeth A Platz; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2011-03-20       Impact factor: 2.506

7.  Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women.

Authors:  Kayoung Lee; Jung Eun Yoo; Tuong Linh Nguyen; John Llewelyn Hopper; Yun-Mi Song
Journal:  Horm Cancer       Date:  2018-07-24       Impact factor: 3.869

8.  Objective habitual physical activity and estradiol levels in obese Latina adolescents.

Authors:  Lauren E Gyllenhammer; Amanda K Vanni; Courtney E Byrd-Williams; Marc Kalan; Leslie Bernstein; Jaimie N Davis
Journal:  J Phys Act Health       Date:  2012-10-04

9.  Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Authors:  Ghada N Farhat; Neeta Parimi; Rowan T Chlebowski; Joann E Manson; Garnet Anderson; Alison J Huang; Eric Vittinghoff; Jennifer S Lee; Andrea Z Lacroix; Jane A Cauley; Rebecca Jackson; Deborah Grady; Dorothy S Lane; Lawrence Phillips; Michael S Simon; Steven R Cummings
Journal:  J Natl Cancer Inst       Date:  2013-09-16       Impact factor: 13.506

10.  Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Authors:  Angela J Fought; Claire McGathey; Denise M Scholtens; Richard E Heinz; Rick Lowe; Yvonne B Feeney; Oukseub Lee; Thomas E Kmiecik; Judith A Wolfman; Charles V Clevenger; Peter H Gann; Susan Gapstur; Robert T Chatterton; Seema A Khan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-18       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.